Literature DB >> 25015835

Activation of rheumatoid factor-specific B cells is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model.

Allison Sang1, Haitao Niu1, Jaime Cullen2, Seung Chul Choi1, Ying Yi Zheng1, Haowei Wang2, Mark J Shlomchik2, Laurence Morel3.   

Abstract

AM14 rheumatoid factor (RF) B cells in the MRL/lpr mice are activated by dual BCR and TLR7/9 ligation and differentiate into plasmablasts via an extrafollicular (EF) route. It was not known whether this mechanism of activation of RF B cells applied to other lupus-prone mouse models. We investigated the mechanisms by which RF B cells break tolerance in the NZM2410-derived B6.Sle1.Sle2.Sle3 (TC) strain in comparison with C57BL/6 (B6) controls, each expressing the AM14 H chain transgene in the presence or absence of the IgG2a(a) autoantigen. The TC, but not B6, genetic background promotes the differentiation of RF B cells into Ab-forming cells (AFCs) in the presence of the autoantigen. Activated RF B cells preferentially differentiated into plasmablasts in EF zones. Contrary to the MRL/lpr strain, TC RF B cells were also located within germinal centers, but only the formation of EF foci was positively correlated with the production of RF AFCs. Immunization of young TC.AM14 H chain transgenic mice with IgG2a(a) anti-chromatin immune complexes (ICs) activated RF B cells in a BCR- and TLR9-dependent manner. However, these IC immunizations did not result in the production of RF AFCs. These results show that RF B cells break tolerance with the same general mechanisms in the TC and the MRL/lpr lupus-prone genetic backgrounds, namely the dual activation of the BCR and TLR9 pathways. There are also distinct differences, such as the presence of RF B cells in GCs and the requirement of chronic IgG2a(a) anti-chromatin ICs for full differentiation of RF AFCs.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25015835      PMCID: PMC4119566          DOI: 10.4049/jimmunol.1303000

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  Identification of anergic B cells within a wild-type repertoire.

Authors:  Kevin T Merrell; Robert J Benschop; Stephen B Gauld; Katja Aviszus; Debora Decote-Ricardo; Lawrence J Wysocki; John C Cambier
Journal:  Immunity       Date:  2006-12       Impact factor: 31.745

2.  Functional outcome of B cell activation by chromatin immune complex engagement of the B cell receptor and TLR9.

Authors:  Liliana Busconi; Jason W Bauer; Joseph R Tumang; Amy Laws; Kristin Perkins-Mesires; Abigail S Tabor; Christina Lau; Ronald B Corley; Thomas L Rothstein; Frances E Lund; Timothy W Behrens; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

3.  Tolerance checkpoints in B-cell development: Johnny B good.

Authors:  Roxane Tussiwand; Nabil Bosco; Rhodri Ceredig; Antonius G Rolink
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

4.  Regulation of B cell tolerance by the lupus susceptibility gene Ly108.

Authors:  Kirthi Raman Kumar; Liunan Li; Mei Yan; Madhavi Bhaskarabhatla; Angela B Mobley; Charles Nguyen; Jill M Mooney; John D Schatzle; Edward K Wakeland; Chandra Mohan
Journal:  Science       Date:  2006-06-16       Impact factor: 47.728

Review 5.  Dysregulation of germinal centres in autoimmune disease.

Authors:  Carola G Vinuesa; Iñaki Sanz; Matthew C Cook
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

6.  Defective B-cell response to T-dependent immunization in lupus-prone mice.

Authors:  Haitao Niu; Eric S Sobel; Laurence Morel
Journal:  Eur J Immunol       Date:  2008-11       Impact factor: 5.532

7.  Antibody clustering helps refine lupus prognosis.

Authors:  Aharon Kessel; Itzhak Rosner; Kathy Halasz; Galia Grushko; Yehuda Shoenfeld; Dafna Paran; Elias Toubi
Journal:  Semin Arthritis Rheum       Date:  2008-06-09       Impact factor: 5.532

8.  Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites.

Authors:  Robin A Herlands; Jacqueline William; Uri Hershberg; Mark J Shlomchik
Journal:  Eur J Immunol       Date:  2007-12       Impact factor: 5.532

Review 9.  Sites and stages of autoreactive B cell activation and regulation.

Authors:  Mark J Shlomchik
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

10.  Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus.

Authors:  Tianfu Wu; Xiangmei Qin; Zoran Kurepa; Kirthi Raman Kumar; Kui Liu; Hasna Kanta; Xin J Zhou; Anne B Satterthwaite; Laurie S Davis; Chandra Mohan
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

View more
  11 in total

1.  Dendritic Cells Regulate Extrafollicular Autoreactive B Cells via T Cells Expressing Fas and Fas Ligand.

Authors:  Michelle L Ols; Jaime L Cullen; Adriana Turqueti-Neves; Josephine Giles; Mark J Shlomchik
Journal:  Immunity       Date:  2016-10-25       Impact factor: 31.745

2.  Requirement for Transcription Factor Ets1 in B Cell Tolerance to Self-Antigens.

Authors:  Lisa Russell; Shinu John; Jaime Cullen; Wei Luo; Mark J Shlomchik; Lee Ann Garrett-Sinha
Journal:  J Immunol       Date:  2015-09-09       Impact factor: 5.422

3.  Relative Contributions of B Cells and Dendritic Cells from Lupus-Prone Mice to CD4+ T Cell Polarization.

Authors:  Seung-Chul Choi; Zhiwei Xu; Wei Li; Hong Yang; Derry C Roopenian; Herbert C Morse; Laurence Morel
Journal:  J Immunol       Date:  2018-03-21       Impact factor: 5.422

4.  Normalization of CD4+ T cell metabolism reverses lupus.

Authors:  Yiming Yin; Seung-Chul Choi; Zhiwei Xu; Daniel J Perry; Howard Seay; Byron P Croker; Eric S Sobel; Todd M Brusko; Laurence Morel
Journal:  Sci Transl Med       Date:  2015-02-11       Impact factor: 17.956

5.  Genetic and cellular dissection of the activation of AM14 rheumatoid factor B cells in a mouse model of lupus.

Authors:  Allison Sang; Ying Yi Zheng; Seung-Chul Choi; Leilani Zeumer; Laurence Morel
Journal:  J Leukoc Biol       Date:  2015-05-08       Impact factor: 4.962

6.  Pharmacologically Inferred Glycolysis and Glutaminolysis Requirement of B Cells in Lupus-Prone Mice.

Authors:  Seung-Chul Choi; Wei Li; Xiaojuan Zhang; Nathalie Kanda; Leilani Zeumer-Spataro; Xiangyu Teng; Laurence Morel
Journal:  J Immunol       Date:  2022-04-06       Impact factor: 5.426

Review 7.  Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity.

Authors:  Rebecca A Elsner; Mark J Shlomchik
Journal:  Immunity       Date:  2020-12-15       Impact factor: 31.745

Review 8.  Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus.

Authors:  Kongyang Ma; Jingyi Li; Yongfei Fang; Liwei Lu
Journal:  Int J Mol Sci       Date:  2015-06-09       Impact factor: 5.923

9.  Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice.

Authors:  Kevin M Nickerson; Yujuan Wang; Sheldon Bastacky; Mark J Shlomchik
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

10.  Innate and adaptive signals enhance differentiation and expansion of dual-antibody autoreactive B cells in lupus.

Authors:  Allison Sang; Thomas Danhorn; Jacob N Peterson; Andrew L Rankin; Brian P O'Connor; Sonia M Leach; Raul M Torres; Roberta Pelanda
Journal:  Nat Commun       Date:  2018-09-28       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.